TAYSHA GENE THERAPIES INC's ticker is TSHA and the CUSIP is 877619106. A total of 44 filers reported holding TAYSHA GENE THERAPIES INC in Q1 2023. The put-call ratio across all filers is 0.67 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,575 | +1115.9% | 3,663,104 | +154.2% | 0.50% | +1553.3% |
| Q2 2023 | $952 | -17.1% | 1,440,882 | 0.0% | 0.03% | -55.9% |
| Q1 2023 | $1,149 | -64.7% | 1,440,882 | 0.0% | 0.07% | -62.6% |
| Q4 2022 | $3,256 | -99.8% | 1,440,882 | +38.4% | 0.18% | +111.6% |
| Q3 2022 | $2,009,000 | -48.1% | 1,040,882 | 0.0% | 0.09% | -58.5% |
| Q2 2022 | $3,872,000 | -42.9% | 1,040,882 | 0.0% | 0.21% | -27.1% |
| Q1 2022 | $6,787,000 | -44.0% | 1,040,882 | 0.0% | 0.28% | -13.7% |
| Q4 2021 | $12,126,000 | -37.4% | 1,040,882 | 0.0% | 0.33% | -24.2% |
| Q3 2021 | $19,381,000 | -12.2% | 1,040,882 | 0.0% | 0.43% | -3.1% |
| Q2 2021 | $22,067,000 | +4.4% | 1,040,882 | 0.0% | 0.45% | +20.1% |
| Q1 2021 | $21,130,000 | -23.5% | 1,040,882 | 0.0% | 0.37% | -37.1% |
| Q4 2020 | $27,625,000 | +8.1% | 1,040,882 | -8.8% | 0.59% | -4.4% |
| Q3 2020 | $25,556,000 | – | 1,140,882 | – | 0.62% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 3,827,926 | $12,096,246 | 8.11% |
| TCG Crossover Management, LLC | 11,111,111 | $35,111,111 | 5.17% |
| VR Adviser, LLC | 14,444,444 | $45,644,443 | 4.80% |
| Kynam Capital Management, LP | 3,281,313 | $10,368,949 | 1.70% |
| Ghost Tree Capital, LLC | 1,325,000 | $4,187,000 | 1.38% |
| Octagon Capital Advisors LP | 2,777,778 | $8,777,778 | 1.35% |
| RA Capital Management | 18,472,503 | $58,373,109 | 1.15% |
| RTW INVESTMENTS, LP | 16,893,185 | $53,382,465 | 1.13% |
| Diametric Capital, LP | 760,014 | $2,401,644 | 1.00% |
| Quantum Private Wealth, LLC | 575,380 | $1,818,201 | 0.87% |